SOURCE: Industrial Info Resources

Industrial Info Resources

January 15, 2016 07:30 ET

Pharma-Biotech Industry Capital Investment Tops $5 Billion for First-Quarter 2016 North American Project Starts, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwired - Jan 15, 2016) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- As the first quarter of 2015 gathers steam, the Pharmaceutical-Biotech Industry is projected to launch over $5 billion worth of North American projects through the end of March. A healthy cash injection of that magnitude is cause for jubilation, or at the least, cautious optimism. This robust investment of capital and maintenance dollars represents a 100% leap over the first-quarter 2015 figure of $2.5 billion. Another heartening aspect about the figures is the fact that quite a few of the first-quarter 2016 projects involve manufacturing expansions.

Within this article: Details of Medicago Incorporated's vaccine production plant project in Quebec City and other pharmaceutical and biotech projects.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News, or browse other breaking industrial news stories at

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, five offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "Contact Us" page.

Contact Information

  • Contact:
    Brian Ford